Literature DB >> 33842094

COVID-19 and Posterior Reversible Encephalopathy Syndrome.

Fabio Noro1, Fernando de Mendonça Cardoso1, Edson Marchiori1.   

Abstract

Entities:  

Year:  2021        PMID: 33842094      PMCID: PMC8032438          DOI: 10.1212/CPJ.0000000000000904

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN: 2163-0402


× No keyword cloud information.
  7 in total

1.  Reversible posterior leukoencephalopathy in a patient with systemic sclerosis/systemic lupus erythematosus overlap syndrome.

Authors:  Patrick F K Yong; Sally M A Hamour; Aine Burns
Journal:  Nephrol Dial Transplant       Date:  2003-12       Impact factor: 5.992

2.  Thrombotic thrombocytopenic purpura: brain CT and MRI findings in 12 patients.

Authors:  R Bakshi; Z A Shaikh; V E Bates; P R Kinkel
Journal:  Neurology       Date:  1999-04-12       Impact factor: 9.910

3.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

Authors:  Dawei Wang; Bo Hu; Chang Hu; Fangfang Zhu; Xing Liu; Jing Zhang; Binbin Wang; Hui Xiang; Zhenshun Cheng; Yong Xiong; Yan Zhao; Yirong Li; Xinghuan Wang; Zhiyong Peng
Journal:  JAMA       Date:  2020-03-17       Impact factor: 56.272

4.  A case of reversible posterior leukoencephalopathy syndrome caused by transient hypercoagulable state induced by infection.

Authors:  Yuichiro Yano; Kazuomi Kario; Takashi Fukunaga; Tomohiko Ohshita; Daisuke Himeji; Michiko Yano; Susumu Nakagawa; Yoichi Sakata; Kazuyuki Shimada
Journal:  Hypertens Res       Date:  2005-07       Impact factor: 3.872

5.  A reversible posterior leukoencephalopathy syndrome.

Authors:  J Hinchey; C Chaves; B Appignani; J Breen; L Pao; A Wang; M S Pessin; C Lamy; J L Mas; L R Caplan
Journal:  N Engl J Med       Date:  1996-02-22       Impact factor: 91.245

Review 6.  Posterior reversible encephalopathy syndrome.

Authors:  Marlene Fischer; Erich Schmutzhard
Journal:  J Neurol       Date:  2017-01-04       Impact factor: 4.849

Review 7.  The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients.

Authors:  Yan-Chao Li; Wan-Zhu Bai; Tsutomu Hashikawa
Journal:  J Med Virol       Date:  2020-03-11       Impact factor: 2.327

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.